# Feasibility Trial of Darwin OncoTreat and OncoTarget Precision Medicine Testing

> **NCT06842030** · NA · NOT_YET_RECRUITING · sponsor: **Good Samaritan Hospital Medical Center, New York** · enrollment: 20 (estimated)

## Conditions studied

- Personalized Medicine
- Oligometastatic Disease
- Feasibility

## Interventions

- **DIAGNOSTIC_TEST:** Darwin OncoTarget and OncoTreat

## Key facts

- **NCT ID:** NCT06842030
- **Lead sponsor:** Good Samaritan Hospital Medical Center, New York
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03-10
- **Primary completion:** 2027-04-10
- **Final completion:** 2027-04-10
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06842030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06842030, "Feasibility Trial of Darwin OncoTreat and OncoTarget Precision Medicine Testing". Retrieved via MORVS 2026-11-17 from https://api.morvs.ai/clinical/NCT06842030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
